著者
Keitaro Senoo Yee Cheng Lau Mikhail Dzeshka Deirdre Lane Ken Okumura Gregory Y.H. Lip
出版者
日本循環器学会
雑誌
Circulation Journal (ISSN:13469843)
巻号頁・発行日
vol.79, no.2, pp.339-345, 2015-01-23 (Released:2015-01-23)
参考文献数
23
被引用文献数
9 34

Background:Non-vitamin K antagonist oral anticoagulants (NOAC) have been developed as alternatives to warfarin. Until recently, the latter was the standard oral anticoagulant for patients with non-valvular atrial fibrillation (NVAF). The efficacy and safety of NOAC in Japanese patients with NVAF has been investigated in small trials or subgroups from global randomized control trials (RCT).Methods and Results:We conducted a systematic review and meta-analysis of RCT, to compare the efficacy and safety of NOAC to those of warfarin in Japanese patients with NVAF. Published research was systematically searched for RCT that compared NOAC to warfarin in Japanese patients with NVAF. Random-effects models were used to pool efficacy and safety data across RCT. Three studies, involving 1,940 patients, were identified. Patients randomized to NOAC had a decreased risk for stroke and systemic thromboembolism (relative risk [RR], 0.45; 95% CI: 0.24–0.85), with a non-significant trend for lower major bleeding (RR, 0.66; 95% CI: 0.29–1.47), intracranial bleeding (RR, 0.46; 95% CI: 0.18–1.16) and gastrointestinal bleeding (RR, 0.52; 95% CI: 0.25–1.08).Conclusions:NOAC are more efficacious than warfarin for the prevention of stroke and systemic embolism in Japanese patients with NVAF. The present findings offer clinicians a more comprehensive picture of NOAC as a therapeutic option to reduce the risk of stroke in Japanese NVAF patients. (Circ J 2015; 79: 339–345)

言及状況

外部データベース (DOI)

Facebook (1 users, 1 posts)

皆さまへ 4/18 の勉強会のシナリオと文献を、関電チームが準備してくださったので、お知らせします。 ご参加いただける方は、当方まで、ご連絡をいただけましたら、幸いです。 なお、当日、緩やかに学びますので、おやつのご持参にお力添えをお願いします。 文献: Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants v ...

収集済み URL リスト